Adenosine-enhanced ischemic preconditioning provides enhanced cardioprotection in the aged heart

Annals of Thoracic Surgery

Volumn 66, Issue 6, 1998, Pages 2037-2043

  McCully, James D ^a,b   Uematsu, Masahisa ^a   Parker, Robert A ^a   Levitsky, Sidney ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b HARVARD INSTITUTES OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE; MAGNESIUM;

AGED; AGING; ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; DRUG EFFICACY; HEART INFARCTION PREVENTION; HEART INFARCTION SIZE; HEART MUSCLE ISCHEMIA; HEART PROTECTION; ISCHEMIC HEART DISEASE; NONHUMAN; PRIORITY JOURNAL; RABBIT; SENESCENCE;

ADENOSINE; AGING; ANIMALS; CARDIOPLEGIC SOLUTIONS; HEART ARREST, INDUCED; ISCHEMIC PRECONDITIONING, MYOCARDIAL; MAGNESIUM; MYOCARDIAL REPERFUSION INJURY; POTASSIUM; RABBITS; VASODILATOR AGENTS;

EID: 0032460091     PISSN: 00034975     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0003-4975(98)01042-X     Document Type: Article

References (20)

1. 1. Lakatta EG. Cardiovascular regulatory mechanisms in advanced age. Physiol Rev 1993;73:413-67.
2. 2. Misare BP, Krukenkamp IB, Levitsky S. Age-dependent sensitivity to unprotected cardiac ischemia: the senescent myocardium. J Thorac Cardiovasc Surg 1992;103:60-4.
3. 3. Tsukube T, McCully JD, Federman M, Krukenkamp IB, Levitsky S. Developmental differences in cytosolic calcium accumulation associated with surgically induced global ischemia: optimization of cardioplegic protection and mechanism of action. J Thorac Cardiovasc Surg 1996;112:175-84.
4. 4. McCully JD, Levitsky S. Myocardial protection in the elderly: biology of the senescent heart. Ann N Y Acad Sci 1996;793: 305-18.
5. 5. Murry CE, Jennings RB, Reimer KA. Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation 1986;74:1124-36.
6. 6. Li GC, Vasquez JA, Gallagher KP, Lucchesi BR. Myocardial protection with preconditioning. Circulation 1990;82:609-19.
7. 7. Lasley RD, Anderson GM, Mentzer RM. Ischemic preconditioning enhances postischemic recovery of function in the rat heart. Cardiovasc Res 1993;27:565-70.
8. 8. Jenkins DP, Pugsley WB, Yellon DM. Ischemic preconditioning in a model of global ischemia: infarct size limitation, but no reduction of stunning. J Mol Cell Cardiol 1995;27:1623-32.
9. 9. Kolocassides KG, Galinanes M, Hearse DJ. Ischemic preconditioning, cardioplegia or both? Differing approaches to myocardial and vascular protection. J Mol Cell Cardiol 1996; 28:623-34.
10. 10. Asimakis GK, Lick SD, Conti VR. Transient ischemia cannot precondition the rabbit heart against postischemic contractile dysfunction. Ann Thorac Surg 1996;62:543-9.
11. 11. McCully JD, Ueumatsu M, Parker RA, Levitsky S. Adenosine enhanced ischemic preconditioning provides enhanced post-ischemic recovery and limitation of infarct size in the rabbit heart. J Thorac Cardiovasc Surg 1998;116:154-62.
12. 12. Lasley RD, Konyn PJ, Hegge JO, Mentzer RM Jr. Effects of ischemic and adenosine preconditioning on interstitial fluid adenosine and myocardial infarct size. Am J Physiol 1995; 269:H1460-6.
13. 13. Schubert T, Vetter H, Owen P, Rechart B, Opie LH. Adenosine cardioplegia. J Thorac Cardiovasc Surg 1989;98:1057-65.
14. 14. Randhawa MPS, Lasley RD, Mentzer RM Jr. Salutary effects of exogenous adenosine on in vivo myocardial stunning. J Thorac Cardiovasc Surg 1995;110:63-74.
15. 15. Kloner RA, Rude RE, Carlson N, Maroko PR, Deboer LWV, Braunwald E. Ultrastructural evidence of microvascular damage and myocardial cell injury after coronary artery occlusion. Which comes first? Circulation 1980;62:945-52.
16. 16. Hearse DJ, Maxwell L, Saldanha C, Gavin JB. The myocardial vasculature during ischemia and reperfusion: a target for injury and protection. J Mol Cell Cardiol 1993; 25:759-800.
17. 17. Sellke FW, Shafique T, Schoen FJ, Weintraub RM. Impaired endothelium-dependent coronary microvascular relaxation after cold potassium cardioplegia and reperfusion. J Thorac Cardiovasc Surg 1993;105:52-8.
18. 18. Mullane K, Galifianes M, Hearse DJ. Amplification of endogenous adenosine by "adenosine regulating agents" a therapeutic approach to the treatment of cardiac ischemic syndromes. In: Abd-Elfattah AS, Wechsler AS, eds. Purines and myocardial protection. New York: Kluwer Publishers, 1996: 231-58.
19. 19. Faris B, Peynet J, Wassef M, et al. Failure of preconditioning to improve postcardioplegia stunning of minimally infarcted hearts. Ann Thorac Surg 1997;64:1735-41.
20. 20. Birnbaum Y, Hale SL, Kloner RA. Differences in reperfusion length following 30 minutes of ischemia in the rabbit influence infarct size, as measured by triphenyl tetrazolium chloride staining. J Mol Cell Cardiol 1997;29:657-66.